Insider Selling: LifeStance Health Group (NASDAQ:LFST) CTO Sells $481,674.90 in Stock

LifeStance Health Group, Inc. (NASDAQ:LFST) CTO Vukasin Paunovich sold 44,394 shares of LifeStance Health Group stock in a transaction on Monday, August 10th. The shares were sold at an average price of $10.85, for a total transaction of $481,674.90. Following the transaction, the chief technology officer owned 247,446 shares in the company, valued at approximately $2,684,789.10. This trade represents a 15.21% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

LifeStance Health Group Trading Up 1.6%

Shares of LFST stock opened at $12.42 on Friday. LifeStance Health Group, Inc. has a 52-week low of $4.77 and a 52-week high of $12.76. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38. The firm has a market capitalization of $4.82 billion, a PE ratio of 95.55 and a beta of 1.14. The stock has a fifty day simple moving average of $10.39 and a two-hundred day simple moving average of $8.22.

LifeStance Health Group (NASDAQ:LFST) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.06 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.03. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%.The business had revenue of $435.35 million for the quarter, compared to analysts’ expectations of $414.58 million. During the same period last year, the firm earned ($0.01) earnings per share. The business’s quarterly revenue was up 26.1% on a year-over-year basis. On average, analysts predict that LifeStance Health Group, Inc. will post 0.15 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in LFST. Larson Financial Group LLC increased its holdings in shares of LifeStance Health Group by 19,952.6% in the fourth quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock worth $27,000 after purchasing an additional 3,791 shares during the last quarter. KBC Group NV bought a new position in LifeStance Health Group during the first quarter valued at approximately $29,000. EverSource Wealth Advisors LLC grew its holdings in LifeStance Health Group by 359.1% during the 1st quarter. EverSource Wealth Advisors LLC now owns 6,909 shares of the company’s stock valued at $44,000 after buying an additional 5,404 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in LifeStance Health Group by 615.3% during the first quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company’s stock valued at $59,000 after purchasing an additional 7,987 shares during the last quarter. Finally, Assetmark Inc. lifted its position in LifeStance Health Group by 17.0% during the first quarter. Assetmark Inc. now owns 9,419 shares of the company’s stock valued at $60,000 after purchasing an additional 1,367 shares during the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on LFST. KeyCorp lifted their target price on LifeStance Health Group from $11.00 to $13.00 and gave the company an “overweight” rating in a research note on Monday, July 13th. Wall Street Zen upgraded LifeStance Health Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday. JPMorgan Chase & Co. increased their price objective on shares of LifeStance Health Group from $9.00 to $13.00 and gave the company a “neutral” rating in a report on Friday. Barclays lifted their price objective on shares of LifeStance Health Group from $9.00 to $13.00 and gave the company an “overweight” rating in a research report on Tuesday, July 14th. Finally, Zacks Research downgraded shares of LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a report on Monday, July 13th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $12.12.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.